Proteomics International Laboratories Ltd (ASX: PIQ) Announces Board and Management Transition
Proteomics International (ASX: PIQ) announces the retirement of Managing Director Dr Richard Lipscombe and the search for his successor.
Category: ASX-PIQ
Proteomics International Laboratories Ltd
Proteomics International Laboratories Ltd (ASX:PIQ) Announces Breakthrough in Equine Muscle Recovery Testing
Proteomics International (ASX:PIQ) unveils the OxiDx test for detecting muscle damage in racehorses, targeting an Australian launch in H2 CY25.
Proteomics International Laboratories Ltd (ASX:PIQ) Launches PromarkerD and Raises $4.5m
Proteomics International (ASX:PIQ) launches PromarkerD test in Australia and secures $4.5m funding to support its precision diagnostics growth.
Proteomics International Laboratories Ltd (ASX:PIQ) Launches Promarker®D Test to Combat Diabetic Kidney Disease in Australia
Proteomics International (ASX:PIQ) launches PromarkerD, a predictive test for diabetic kidney disease, enhancing early diagnosis and intervention.